Spectrum Pharmaceuticals (NASDAQ: SPPI)
Some price data may be temporarily unavailable.
Spectrum Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Spectrum Pharmaceuticals Company Info
A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.
News & Analysis
Why Spectrum Pharmaceuticals Stock Is Crashing Today
The company received a thumbs-down from the FDA for its lead pipeline candidate.
Why Spectrum Pharmaceuticals Is Plunging Today
The company announced the pricing of a public offering of common stock.
Why Spectrum Pharmaceuticals Stock Is on Fire Today
Spectrum scores a key win in the clinic with its experimental lung cancer drug.
2 Top Cancer Treatment Stocks To Watch In July
These hidden gems have the potential to deliver significant returns to their shareholders over the long run.
Why Spectrum Pharmaceuticals Rose 19% Today
Shares jumped even though the company reported disappointing earnings. What can explain the boost?
Stock Market News: HEXO Heads Lower; Spectrum Can't Stay Healthy
Stocks were modestly higher on the day after the Christmas holiday.
Why J.C. Penney, Tesla, and Spectrum Pharmaceuticals Slumped Today
More retail struggles sent the department store giant lower.
Here's Why Spectrum Pharmaceuticals Fell as Much as 13.1% Today
The biopharma announced that one of its drug candidates is closer to hitting the market, but investors aren't in a celebratory mood.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.